Analysts think Merck KGaA is fairly priced

Merck KGaA KGaA's stock price seems, partly because of the recent share price rises, to be in line with most of the estimates. Most of the analysts say Merck KGaA KGaA is fairly priced now. Currently the company is being followed by 16 analysts. The average of the actual target prices for the stock equals 98,75 euros. This is at around 2 percent more than the current price of 96,52 euros.

Target prices for Merck KGaA KGaA quite spread

For this year Merck KGaA KGaA's revenue will be around 14,67 billion euros. This is according to the average of the analysts' estimates. This is slightly lower than 2017's revenue of 15,33 billion euros.

Historical revenues and results Merck KGaA KGaA plus estimates 2018

The analysts expect for 2018 a net profit of 2,3 billion euros. Most of the analysts anticipate on a profit per share of 5,17 euros. So the price/earnings-ratio equals 18,67.

Per share the analysts are expecting a dividend of 1,27 euros per share. Merck KGaA KGaA's dividend yield thus equals 1,32 percent. The average dividend yield of the pharmaceutical companies equals a limited 0,5 percent.

Newest target prices around 96 euros

Merck KGaA KGaA's market capitalization is based on the number of outstanding shares around 12,47 billion euros. The Merck KGaA KGaA stock was the past 12 months quite volatile. Since last December the stock is 8 percent higher. This year the stock price moved between 75 and 100 euro. Since 2008 the stock price is almost 228 percent higher.

Price data Merck KGaA KGaA 2007-2018

At 11.17 the stock trades 0,02 percent higher at 96,52 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.